Vous êtes sur la page 1sur 4

Syed Jamals Case history at @

glance
Sl
no.
1

Date

Report

Findings

19/03/12

EchoUSGTMT-

Normal Echo cardiogram.


Normal ultra-scan.
Stress test is negative for
Inducible Ischemia.

20/03/12

Holter-1

Tachycardia syndrome,
Mobitz type 2 Av block.

09/04/12

USG-

No significant sonological
abnormality seen.

Hematology

Normal test Result.

Normal

01/05/12

Urine for V.M.A


Dr. Prescription

C/o palpitation, on & off for 2


month associated with
Nausea / restlessness. No
c/o chest pain, Diagnosis
with GERD- Hiatus Hernia. No
F/H of CAD. Smoker - 12 yrs
& stopped since 2 month.
K/C/O DM/Asthma / HTN.

08/05/12

PETCT

No evidence of enhancing
focus or abnormal
somatostatin receptor avid
lesion in this study. / No
evidence of SSR expressing
neuroendocrine tumor.

14.4 mg/dl ( 19-43) Low


Creatinine normal

08/05/12

09/05/12

13/05/12

Serum urea

Holter-2

Intermittent first degree,


Mobitz type 1 & 2 AV block
with longest sinus pause of
180ms. No other arrhythmias
noted.

PCV-49.4 H (36.0-46.0) High

CBC/DC/KFT

Remarks

Holter
report 1
attached

Holter
report 2
Attached

Syed Jamals Case history at @


glance

14/5/12

Dr. advice

02/05/14

Dr. Prescribed

22/05/14

Dr. Prescribed

06/06/15

Fast path
summary

20/07/15

Dr. Prescribed

06/08/15

ECG

07/08/15

Holter-3

17/08/15

Dr. prescribed

TC-11.2 H (4.0-11.0) High.


Neutrophils- 80.2 H (4.911.0)
Lymphocytes-14.0 L (20.045.0)
Eosinophils-0.7 L (0.0-1.0)
Potassium-3.4 L (3.5-5.0)
VDDR/Pacemaker implant
(Double chamber)
Indication- 2.1 Block.
Permanent pace maker
implanted. Result
satisfactory.
S/o Sinus Tachycardia.
T. Metolar 50 mg or Seloken
XL 50 mg/25 mg (1-0-1).
T. Seloken XL 25 mg (1-0-1),
T. sompraz D (1-0-0)
98% paced with 150 ms
delays now goes to 250 ms
delay. Sensed Av delay 200
ms Auto intrinsic conduction
delay 50 ms.
Prolomet XL 50 mg (1-0-0), T.
omez 20 mg (1-0-1). Bp130/80 mmhg, pulse- 80bpm,
weight-77 kg.
Probably MI, tachycardia,
minor let axis deviation,
slightly depressed ST
segment , T- wave near base
line.
Minimum heart rate-49 bpm,
maximum heart rate- 135
bpm, Average heart rate-73
bpm, 4% total beats are
tachycardia, 9% total beats
bradycardia.

Pacemaker
1

Holter
report 3
Attached

Syed Jamals Case history at @


glance
31/08/15

Dr. prescribed

21/10/15

Fast path
summary

21/10/15

Holter-4

29/10/15

T. prolomet XL 50mg (1-0-0),


Betaloc 25 mg (1-0-1), Alprax
0.25 mg (0-0-1).

Betaloc 25 mg (1-0-1), Alprax


0.25 mg (0-0-1), Tab. Pan D
(1-0-1).
Base rate reduce to 30bpm
with VVIR mode 140bpm
max rate for holter
monitoring.

24 hrs monitoring revealed a


maximum heart rate of 129
bpm (sinus tachycardia) and
a minimum heart rate 39
bpm (sinus bradycardia).
There were no pauses or VT /
SVT observed during the
study.

T. prolomet XL 50mg (1-0-1),


Tab Pan D (1-0-1).
General ExaminationAnxiety neuro

Dr. prescribed

08/11/15

ECG

10

09/11/15

Bio-chemistry

Sinus rhythm with marked


sinus arrhythmia, possible
left atrial enlargement,
septal infarct, age
undetermined, possible
inferior infarct, abnormal
ECG.
Calcium-10.04 mg/dl (8.610.0)
Magnesium-2.1 mg/dl (1.82.6)
Creatinine normal
Blood urea nitrogen normal.
Uric acid normal
Lipid profile normal
Homocysteine normal
LFT: SGPT-73 IU/L (0-45),

Pacemaker
2

Holter
report 4
attached

Syed Jamals Case history at @


glance

11

Current
medication

GGT-115 IU/L (0-55).


Urine routine normal
C-REACTIVE PROTINE
Normal
CBC: RBC- 6.46 million/ul
(4.5-5.5), MCV-75.9 fl (8395), MCH-26.0 pg (27-32),
Free T3 Free T4 and TSH
normal.
Betaloc 25 mg (1-0-1), Alprax
0.25 mg (0-0-1).

Vous aimerez peut-être aussi